275 related articles for article (PubMed ID: 24525740)
1. Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay.
Macarthur KM; Kao GD; Chandrasekaran S; Alonso-Basanta M; Chapman C; Lustig RA; Wileyto EP; Hahn SM; Dorsey JF
Cancer Res; 2014 Apr; 74(8):2152-9. PubMed ID: 24525740
[TBL] [Abstract][Full Text] [Related]
2. Circulating Biomarkers for Glioma: A Review.
Jones J; Nguyen H; Drummond K; Morokoff A
Neurosurgery; 2021 Feb; 88(3):E221-E230. PubMed ID: 33442748
[TBL] [Abstract][Full Text] [Related]
3. Application of a telomerase-based circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapy: a case study.
Ju M; Kao GD; Steinmetz D; Chandrasekaran S; Keefe SM; Guzzo TJ; Christodouleas JP; Hahn SM; Dorsey JF
Cancer Biol Ther; 2014 Jun; 15(6):683-7. PubMed ID: 24618718
[TBL] [Abstract][Full Text] [Related]
4. Circulating Glioma Cells Exhibit Stem Cell-like Properties.
Liu T; Xu H; Huang M; Ma W; Saxena D; Lustig RA; Alonso-Basanta M; Zhang Z; O'Rourke DM; Zhang L; Gong Y; Kao GD; Dorsey JF; Fan Y
Cancer Res; 2018 Dec; 78(23):6632-6642. PubMed ID: 30322863
[TBL] [Abstract][Full Text] [Related]
5. High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity.
Fizazi K; Morat L; Chauveinc L; Prapotnich D; De Crevoisier R; Escudier B; Cathelineau X; Rozet F; Vallancien G; Sabatier L; Soria JC
Ann Oncol; 2007 Mar; 18(3):518-21. PubMed ID: 17322541
[TBL] [Abstract][Full Text] [Related]
6. Telomerase-positive circulating tumor cells are associated with poor prognosis via a neutrophil-mediated inflammatory immune environment in glioma.
Zhang W; Qin T; Yang Z; Yin L; Zhao C; Feng L; Lin S; Liu B; Cheng S; Zhang K
BMC Med; 2021 Nov; 19(1):277. PubMed ID: 34763698
[TBL] [Abstract][Full Text] [Related]
7. Clonality of circulating tumor cells in breast cancer brain metastasis patients.
Riebensahm C; Joosse SA; Mohme M; Hanssen A; Matschke J; Goy Y; Witzel I; Lamszus K; Kropidlowski J; Petersen C; Kolb-Kokocinski A; Sauer S; Borgmann K; Glatzel M; Müller V; Westphal M; Riethdorf S; Pantel K; Wikman H
Breast Cancer Res; 2019 Sep; 21(1):101. PubMed ID: 31481116
[TBL] [Abstract][Full Text] [Related]
8. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
[TBL] [Abstract][Full Text] [Related]
9. Telomerase expression in intracranial tumours: prognostic potential for malignant gliomas and meningiomas.
Falchetti ML; Pallini R; Larocca LM; Verna R; D'Ambrosio E
J Clin Pathol; 1999 Mar; 52(3):234-6. PubMed ID: 10450187
[TBL] [Abstract][Full Text] [Related]
10. A Combinatory Strategy for Detection of Live CTCs Using Microfiltration and a New Telomerase-Selective Adenovirus.
Ma Y; Hao S; Wang S; Zhao Y; Lim B; Lei M; Spector DJ; El-Deiry WS; Zheng SY; Zhu J
Mol Cancer Ther; 2015 Mar; 14(3):835-43. PubMed ID: 25589497
[TBL] [Abstract][Full Text] [Related]
11. A novel approach for the detection and genetic analysis of live melanoma circulating tumor cells.
Xu MJ; Cooke M; Steinmetz D; Karakousis G; Saxena D; Bartlett E; Xu X; Hahn SM; Dorsey JF; Kao GD
PLoS One; 2015; 10(3):e0123376. PubMed ID: 25807549
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
Gandhi P; Khare R; Garg N
J Neurooncol; 2017 Nov; 135(2):255-261. PubMed ID: 28756592
[TBL] [Abstract][Full Text] [Related]
13. Tumor-selective replication herpes simplex virus-based technology significantly improves clinical detection and prognostication of viable circulating tumor cells.
Zhang W; Bao L; Yang S; Qian Z; Dong M; Yin L; Zhao Q; Ge K; Deng Z; Zhang J; Qi F; An Z; Yu Y; Wang Q; Wu R; Fan F; Zhang L; Chen X; Na Y; Feng L; Liu L; Zhu Y; Qin T; Zhang S; Zhang Y; Zhang X; Wang J; Yi X; Zou L; Xin HW; Ditzel HJ; Gao H; Zhang K; Liu B; Cheng S
Oncotarget; 2016 Jun; 7(26):39768-39783. PubMed ID: 27206795
[TBL] [Abstract][Full Text] [Related]
14. Detection of circulating tumor cells in cervical cancer using a conditionally replicative adenovirus targeting telomerase-positive cells.
Takakura M; Matsumoto T; Nakamura M; Mizumoto Y; Myojyo S; Yamazaki R; Iwadare J; Bono Y; Orisaka S; Obata T; Iizuka T; Kagami K; Nakayama K; Hayakawa H; Sakurai F; Mizuguchi H; Urata Y; Fujiwara T; Kyo S; Sasagawa T; Fujiwara H
Cancer Sci; 2018 Jan; 109(1):231-240. PubMed ID: 29151279
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study.
Hinz S; Hendricks A; Wittig A; Schafmayer C; Tepel J; Kalthoff H; Becker T; Röder C
BMC Cancer; 2017 Jan; 17(1):53. PubMed ID: 28086834
[TBL] [Abstract][Full Text] [Related]
16. Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patients.
Breitenbuecher F; Hoffarth S; Worm K; Cortes-Incio D; Gauler TC; Köhler J; Herold T; Schmid KW; Freitag L; Kasper S; Schuler M
PLoS One; 2014; 9(1):e85350. PubMed ID: 24465542
[TBL] [Abstract][Full Text] [Related]
17. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
[TBL] [Abstract][Full Text] [Related]
18. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
[TBL] [Abstract][Full Text] [Related]
19. A rapid and quantitative method to detect human circulating tumor cells in a preclinical animal model.
Tu SH; Hsieh YC; Huang LC; Lin CY; Hsu KW; Hsieh WS; Chi WM; Lee CH
BMC Cancer; 2017 Jun; 17(1):440. PubMed ID: 28645267
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age.
Lötsch D; Ghanim B; Laaber M; Wurm G; Weis S; Lenz S; Webersinke G; Pichler J; Berger W; Spiegl-Kreinecker S
Neuro Oncol; 2013 Apr; 15(4):423-32. PubMed ID: 23393205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
